Free Access
Med Sci (Paris)
Volume 29, Number 11, Novembre 2013
Page(s) 954 - 956
Section Nouvelles
Published online 20 November 2013
  1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008 ; 454 : 436–444. [CrossRef] [PubMed] [Google Scholar]
  2. Riordan SM, Williams R. The intestinal flora and bacterial infection in cirrhosis. J Hepatol 2006 ; 45 : 744–757. [CrossRef] [PubMed] [Google Scholar]
  3. Yu LX, Yan HX, Liu Q, et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 2010 ; 52 : 1322–1333. [CrossRef] [PubMed] [Google Scholar]
  4. Dapito DH, Mencin A, Gwak GY, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012 ; 21 : 504–516. [CrossRef] [PubMed] [Google Scholar]
  5. Wang Z, Yan J, Lin H, et al. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice. Hepatology 2013 ; 57 : 1869–1881. [CrossRef] [PubMed] [Google Scholar]
  6. Zhang HL, Yu LX, Yang W, et al. Profound impact of gut homeostasis on chemically induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol 2012 ; 57 : 803–812. [CrossRef] [PubMed] [Google Scholar]
  7. McKnite AM, Perez-Munoz ME, Lu L, et al. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One 2012 ; 7 : e39191. [CrossRef] [PubMed] [Google Scholar]
  8. Friswell MK, Gika H, Stratford IJ, et al. Site and strain-specific variation in gut microbiota profiles, metabolism in experimental mice. PLoS One 2010 ; 5 : e8584. [CrossRef] [PubMed] [Google Scholar]
  9. Agundez JA, Garcia-Martin E, Devesa MJ, et al. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology 2012 ; 82 : 35–40. [CrossRef] [PubMed] [Google Scholar]
  10. Liang B, Chen R, Wang T, et al. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma. Clin Cancer Res 2013 ; 19 : 2905–2916. [CrossRef] [PubMed] [Google Scholar]
  11. Burcelin R, Chabo C, Blasco-Baque V, et al. Le microbiote intestinal à l’origine de nouvelles perspectives thérapeutiques pour les maladies métaboliques ? Med Sci (Paris) 2013 ; 29 : 800–806. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Hoarau G, Colombel JF, Poulain D, Sendid B. Implication de la flore fongique intestinale dans le développement de la maladie de Crohn. Med Sci (Paris) 2013 ; 29 : 691–693. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. Imler JL, Ferrandon D. Le printemps de l’immunité innée couronné à Stockholm. Med Sci (Paris) 2011 ; 27 : 1019–1024. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Jamilloux Y, Henry T. Les inflammasomes : plates-formes de l’immunité innée. Med Sci (Paris) 2013 ; 29 : 975–984. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.